Call for Papers

The organizing committee of the 52nd Annual Scientific Meeting of the Japan Atherosclerosis Society encourages abstract submission widely from overseas.
All the abstracts submitted are rated and selected for presentation by the organizing committee.

Abstract Submission Period

Free paper

Thursday, December 12, 2019 to Thursday, January 23, 2020

extended until Monday, February 10 at 12:00 (JST)

Abstract submission is closed.
Thank you for your submission.

Submissions, modifications, or deletions of abstracts will not be accepted after the deadline. Traffic to the site is expected to be heavy close to the deadline, which may cause a delay in processing the submission of your abstract. You are recommended to submit abstracts as early as possible.

Abstract contents submitted online may be modified until the deadline. Please note that you may not be able to make modifications just before the deadline if traffic is heavy.

Changes, such as to the names of co-authors, after the deadline will not be accepted. Please be sure to include those corrections during the abstract submission period.

Symposium

Thursday, December 12, 2019 to Wednesday, January 15, 2020

Abstract Submission is closed.

Grant for participants from overseas

If you want to apply for a grant, please click “Grant for participants from overseas” in the online abstract submission system.

The applicants from overseas affiliations will be evaluated from the abstract, and the awards will be granted to the ten most outstanding researches on the atherosclerosis. A selected applicant will receive a grant (from JPY125,000 to JPY200,000, depending on the location of the country).

Disclosure of Conflict of Interest (COI)

A disclosure statement of conflict of interest (COI) must be submitted along with the abstract. It is the author's responsibility to report any real or perceived financial conflict of interest. Any potential for financial gain that may be derived from reported work may constitute a potential conflict of interest. Disclosure is required in any case in which an individual or company stands to benefit financially from research performed. Therefore, the onus is on each author to disclose any financial benefit to an individual or company.

For Questions regarding COI disclosure
Japan Atherosclerosis Society E-mail: jas@j-athero.or.jp

Procedures for Submitting Abstracts and Disclosure of Conflict of Interest (COI)

STEP 1: Creation of COI Disclosure Statement

Click on the button below to download the COI Disclosure Statement.

Save the downloaded COI Disclosure Statement to your desktop. Change the file name to “52JAS_COI (Presenter’s LAST NAME FIRST NAME)

Open the COI Disclosure Statement saved to your desktop and fill in the necessary items.

* Even if you have no potential conflicts of interest, please check the “No” box. Save the COI Disclosure Statement in which you have included the necessary items.

* This COI Disclosure Statement will be uploaded later.

STEP 2: Submission of Abstracts [Example]

Fill in all required items on the Abstract Submission page.
After filling in the information, click the “Proceed to submit” button displayed at the bottom of the page.

A confirmation page showing the information on your submission will be displayed. Confirm that there are no mistakes in the submission contents and click the “Submit (登録)” button displayed at the bottom of the page.

Your “Registration Number” and “Password for Reference/Updates” will be displayed. Print out this page to save your information.

* Please do not close the screen. You will upload the COI Disclosure Statement from this screen.

[How to upload the chart or diagram]

STEP 3: Upload the COI Disclosure Statement

Click on the “Upload Document (論文ファイルアップロード)” button at the bottom of the screen. (The “COI (Conflict of Interest) File Submission” screen to upload the COI Disclosure Statement created in STEP 1 will be displayed.)

Click the “Browse” or “Select File (参照)” button. (The name of the button may differ depending on the browser used.)

Select the COI Disclosure Statement created in STEP 1 from the file selection screen.

Click the “Start Upload (アップロード開始)” button.

Check that the “Upload Completed Successfully (アップロードは正常に終了しました)” window is displayed.

* If this is displayed on your screen, the COI Disclosure Statement has been uploaded.

Call for Papers

  • Submission Type:公募演題 [Call for Papers]

[Call for Papers] Presentation Method:

  • Symposium:Inflammation & Immunity related to atherosclerosis
    (English presentation)
  • Symposium:Vascular diseases and regenerative medicine (English presentation)
  • Free paper:Oral (English presentation)
  • Free paper:Poster (English presentation)
  • Free paper:Either Oral or Poster (English presentation)

[Call for Papers] English Category:

01 Basic research Vascular biology・Angiogenesis
02 Pathology
03 Inflammation・Cytokine
04 Intracellular signaling・Cell
05 Animal experiments・Model animal
06 Thrombosis and hemostasis・Coagulation and fibrinolysis
07 Miscellaneous
08 Atherosclerosis and
related diseases
Hypertension
09 Diabetes・Endocrine disorders・Metabolic syndorome・Obesity
10 Renal disease・CKD
11 NAFLD/NASH・Fatty liver・Steatohepatitis
12 Miscellaneous
13 Dyslipidemia and
its analysis
Choresterol・Choresterol derivatives
14 Fatty Acid・Triglyceride・Phospholipid
15 Lipoprotein metabolism・Lipoprotein receptor
16 Reverse cholesterol transport system・HDL Function
17 Lipid absorption and postprandial lipemia
18 Familial hypercholesterolemia
19 Dyslipidemia
20 Dyslipidemia・atherosclerosis in women and children
21 Dyslipidemia and examination
22 Miscellaneous
23 Therapeutic
intervention
Diet therapy/Nutritional therapy/Functional food
24 Exercise therapy
25 Drug therapy・Antibody drugs
26 Miscellaneous
27 Atherosclerotic disease
and
evaluation treatment
Epidemiological study・Observational studies
28 Image inspection・Imaging・Vascular function evaluation
29 Acute coronary syndrome・Angina
30 Cerebrovascular disease
31 Cerebrovascular disease・Vascular dementia
32 Aging・Care
33 Medical checkup・Preventive medicine・Industrial and labor hygiene
34 Miscellaneous
35 Medical staff session Industrial hygiene・Health care・Preventive medicine
36 Drugs
37 Nutritional management
38 Clinical examination
39 Nursing・Care・Primary care
40 Miscellaneous

You may be asked to deliver your presentation in a category that is different from the one you specified when submitting your abstract, depending on the program setup. Thank you for your understanding.

Word Limits

  • Author information and abstracts must be submitted in English.
  • Abstract title must be up to 200 letters.
  • Abstract text must be up to 1,400 letters.
  • The maximum of 15 authors (first author & co-authors) can be registered.
  • The maximum of 10 affiliations (including the affiliation of the first author) can be registered.
  • If possible, please structure your abstract with:
    ・Background:
    ・Methods:
    ・Results:
    ・Conclusion:
  • Only one chart or diagram is permitted. If you apply a chart or diagram, the abstract text should be limited to 600 letters.

Guidelines for Submission

The following browsers can be used with this abstract submission system.

Firefox Google
Chrome
Internet
Explorer
Microsoft
Edge
Safari
Windows
Mac

Complete setting password and submission, Confirmation and modifications of submitted abstracts

When submitting an abstract for the first time, registrants will need to decide on an optional password.

After the submission of your abstract is complete, a registration number (10000 series) will be issued automatically. The submission process for the abstract is complete when this registration number is issued (A message confirming registration will be sent.). If the registration number does not appear on the screen, the submission has not been received.

Use the confirmation/modification button to make corrections to submitted abstracts. You can modify and check the abstract as many times as you like by entering the registration number and your password until the submission period deadline. You may also delete your submission. Note that if you click the new “Submit (登録)” button each time you modify the contents, there will be duplicate submissions of the same abstract.

Registrants must keep a record of the registration number and password issued to them. We will not respond to inquiries about registration numbers or passwords to prevent browsing and misuse by third parties.

Registrants using WEB mail (Gmail, Yahoo! mail, other)

There have been many cases where emails from Organizer or Secretariat of this Meeting have been sent to “Junk” folders. If you believe that you have not received a message from us, check the Junk folder first. If you have a “Spam Mail Folder” on your WEB mail account, in addition to your mail software’s Junk mail folder, check that as well.

Notes on Entering Information

  • Left justify information entered in the column. Do the same in the abstract text column.
  • Columns marked as “required” are mandatory. You will not be able to register unless you entry information into these fields.
  • The submitted contents will be posted in programs and abstract collections. In principle, the information will be used as is, without changes to the submitted data. Abstracts will be posted as received, even if there are misspellings. Please check your paper before submission.

Fonts

  • If you will be using Greek fonts, use the symbols in the table below. If you use half-width symbol typefaces (single-byte characters), it will be automatically converted to another typeface (Ex.: αβγ → abc). Please avoid using these typefaces.
Characters α β γ δ ε ζ
Enter α β γ δ ε ζ
Characters η θ ι κ λ μ
Enter η θ ι κ λ μ
Characters ν ξ ο π ρ σ
Enter ν ξ ο π ρ σ
Characters τ υ φ χ ψ ω
Enter τ υ φ χ ψ ω
  • When using English letters and numbers, be sure to distinguish between O (letter) and 0 (number), l (small letter L) and 1 (number), and X (letter) and × (multiplication symbol).
  • Be sure to distinguish between katakana-hiragana prolonged sound marks (ー) and dashes (―), minus symbols (-) and hyphens (-).
  • When entering information in English, do not break up single words with hyphens (-).
  • JCharacters and decorative fonts that are not compliant with JIS standards cannot be used. If you use these characters, you will be cautioned when your submission is being confirmed and will be unable to submit your abstract.
    Ex.: Number enclosed within a circle (①, ❶)
  • Superscripts, subscripts, italics, bold letters, line breaks, and underlined words can be used in the title and text of the abstract. Set these according to usage in the table below. Use half-width characters (single-byte characters) for all symbols (<, >, /). Use full-width characters (double-byte characters) (<, >) as inequality signs in the text.
Character
modifications
Setup Setting example Display
example
Superscripts Enclose the beginning and end of text with <SUP> and </SUP> Na<SUP>+</SUP> Na
Subscript Enclose the beginning and end of text with <SUB> and </SUB> H<SUB>2</SUB>O H2O
Italics Enclose the beginning and end of text with <I> and </I> <I>c-fos</I> c-fos
Bold Enclose the beginning and end of text with <B> and </B> <B>Bold</B> Bold
Underline Enclose the beginning and end of text with <U> and </U> <U>Underline</U> Underline

Completion of Submission

  • After the submission of your abstract is complete, a registration number (10000 series) will be displayed on the screen and an email indicating that your registration is complete will be immediately sent to the email address of the first author registered. This registration number and confirmation email indicate that your abstract has been received.
  • If you do not receive an email indicating that your registration is complete, it is possible that the email address you have registered is incorrect. Check that the email address of the first author has been entered correctly on the confirmation/modification page.
  • Information on the acceptance or rejection of the abstract and the date and time of the accepted presentation will be sent to this address. Be sure to check that you can receive the confirmation messages for registration or modifications.

New submission or modification of abstract

* The personal information registered will not be used for any purposes other than for the preparation of the 52nd Annual Scientific Meeting of the Japan Atherosclerosis Society. We will take the necessary security measures to strictly protect the personal information registered.

Modifications to COI Disclosure Statement

Upload the COI Disclosure Statement again if you wish to modify (update) the COI. Create and save the modified (updated) COI Disclosure Statement.

  • Click the “COI Disclosure Statement Registration” button below to open the COI (Conflict of Interest) Disclosure Statement File Registration screen.
  • Enter the registration number and password for the abstract and click “Proceed to Paper Submission Screen”.
  • When you click the “Modify Paper” button, the same screen as the one when you first uploaded the COI Disclosure Statement will open. Upload a new COI Disclosure Statement through the same procedure.

* When the upload is complete, the COI Disclosure Statement will be saved as the new version.

Acceptance/Rejection of Abstract

  • Submitted abstracts will be reviewed by the program committee and a decision will be made to accept or reject the submission.
  • Notification of acceptance/rejection will be sent to the first author’s email address registered by the beginning of April.

Inquiries for Abstract Submission

Congress Secretariat
c/o Congress Corporation
Daiichi seimei Bldg., 2-13 Shinsakae-machi Naka-ku, Nagoya 460-0004 Japan
Phone: +81-52-950-3369 Fax: +81-52-950-3370
E-mail: jas52@congre.co.jp

ページトップ